Hughlings Jackson (1882) in a lecture given at Worcester said concerning a patient that 'We have to note the tendencies he inherits, as well as to examine him to see how they are particularly evidenced in one branch or twig of a family tree' and it is of interest that this was stated 26 years before Garrod introduced his concept of inborn errors of metabolism (Garrod 1908) . Such disorders were understood to mean, at least when I commenced working with Dr J G Greenfield, those diseases which were frequently inherited and in which some special biochemical abnormality was apparent. Thus Garrod had described such conditions as alkaptonuria and cystinuria.
In 1934, a year after I went to Queen Square, Folling observed that the urine of some mentally defective children in Norway reacted in a specific way with a weak ferric chloride solution, and so he became the first to recognize phenylketonuria biochemically. Since then an increasing number of such disorders have been described and, as each condition was recorded, biochemists attempted to determine the appropriate metabolic pathways involved in normal subjects and where, in patients, these pathways were faulty. Some of these inborn errors and the sites of the metabolic errors will be described, but one more general comment must first be made. Recognizing that frequently a disorder was inherited, geneticists and biochemists discussed means by which inheritance was possible; it has now become a fairly generally accepted principle that coding and the 'master chemical' of the cell are functionally the responsibility of DNA. There have been those who claim that DNA is not of itself responsible but that a DNA polymerase and a synthetase are also involved in the abnormality of the protein molecule and that abnormality is seen by an enzyme deficiency in each particular patient. It may be an enzymic protein or a structural protein or polypeptide arising from the regulatory genes that is in error, but one most not forget that a repressor protein (Bretscher 1968) may be abnormal and that the i gene is the structural gene for this repressor. My own experience in this field includes diseases listed in Table 1 , but this does not include all conditions that could be accepted, nor does it include a number of conditions which are of a doubtful etiology. Three, conditions are indicated which will be considered in some detail, together with an indication of the-frequency with which they have been seen. The main purpose will be to illustrate the biochemical abnormalities, to indicate schemes of classification as well as to demonstrate the very wide range of opportunity that exists to workers in the field of neurochemistry in relation to human disease.
COPPER AS A TRACE METAL IN DISEASE
A personal interest in hepatolenticular degeneration commenced through a study of various heavy metals in the brain in normal subjects and in various abnormal states. It happened that of my early subjects three patients had died with hepatolenticular degeneration or Wilson's disease and in 1948 evidence was presented of a deposition of copper in liver and brain and in the discussion I said: 'It would seem possible that hepatolenticular degeneration is an inborn error in mineral metabolism' (Cumings 1948) . This suggestion was borne out by future observations, even though the exact nature of the disorder is still unknown. Yet through the efforts of research workers, therapy has enabled many patients to survive for considerable periods of active life, demonstrating that treatment may sometimes precede full knowledge.
I shall not repeat the picture of the condition as already presented in 1967 at a Foundation Lecture of the Association of Clinical Pathologists (Cumings 1968) but it is necessary to bring it up to date in a few particulars. I have now made biochemical studies in 95 patients with this condition and Table 2 gives the results. The sex ratio remains the same as previously, 3 males: 2 females. The Kayser-Fleischer ring is the one clinical feature in a patient of more than 12 years of age which is invariably present. The five in whom it was absent were young children with no neurological symptoms or signs apart from features resulting from cirrhosis of the liver. In only three patients have serum copper and ceruloplasmin levels been normal prior to treatment, but each showed the Kayser-Fleischer zone of pigmentation. Another variation from normal copper metabolism should be mentioned. In primary biliary cirrhosis blood levels of copper and cieuloplasmin are frequently raised and there is an increased urinary copper excretion. Results from ten cases Ga  160   34  280  Fi  117  34  323  Fo  203   44  192  Kr  174  50  162  Ly  183  50  90  Mu  137  42  229  Ma  166  40  268  Sh  253  50  244  St  113  38  194 are recorded in Table 3 but no suggestion as to the mechanism involved can be made. Normal values.have been seen in cystinuria and in infants as well as young children, but in those children with cirrhosis of primary biliary type the findings are similar to those of adults, although not so pronounced.
What is the effect of penicillamine in normal subjects and can one use it as a tool to distinguish normal from abnormal? During the course of my investigations the effect of 900-1,000 mg per day penidillamine on urinary copper excretion in control subjects has been assessed and compared with the results in a selection of patients with hepatolenticular degeneration. The selection has been in choosing those in whom no previous treatment had been given and where it was possible to conduct adequate examinations. Fig 1 shows some of the results obtained. There is a striking difference but I doubt the need for this method of differentiationa slit lamp examination is easier in adults.
Has therapy really been of value? There is absolutely no doubt that BAL and even more definitely penicillamine, for which we are indebted to Dr J M Walshe, have both prolonged life and rendered the patients more effective citizens. Let me illustrate by describing one patient, originally under the care of Dr D Brinton and more recently of Dr P Gautier-Smith. She was first seen in 1956, aged 30, and is now 45. In 1956 she had had tremor of the hands for 1 years with defective speech for 1+ years, and had given up her secretarial duties a year previously. On exammation she-presented with the typical clinical features of hepatolenticular degeneration including a Kayser-Fleischer ring. Her serum copper and c2ruloplasmin levels were considerably reduced and the urine copper was raised. She has been seen and reassessed on fourteen occasions over the past 14 years with little variation in serum levels of copper (see Cumings 1968, Fig 4) . It should be mentioned that about 10 years ago the liver and spleen became palpable but as recently as last year no oesophageal varices were observable radiologically. Her treatment has included BAL, given initially, potassium sulphide and penicillamine. Whereas originally she could not hold a cup without spilling its contents, could not dress, could not do her own cooking or housework, and could not write without holding her wrist with the other hand, all these activities can now be accomplished, and in addition her ability to speak has improved. Even as early as 1960 it was reported that 'this patient has responded fairly well to treatment'. This woman with hepatolenticular degeneration of about 16 years' duration has improved clinically and socially very considerably, even though biochemically there has been no change as evidenced by the copper studies carried out.
However, when one turns to the question of the mechanism of the disorder I doubt if there is anything further to be added to that which has already been written. The fact that it is genetically determined is sound and that copper metabolism is at fault cannot be ignored. It must be assumed that there is an enzymic fault, but which enzyme is involved is still a mystery. Is there an enzyme which participates in the transfer of copper from albumin to the apociruloplasmin and is this absent or deficient? Is this enzyme also involved in iron transport and can it be related to the increased copper absorption from the gut? Recent work has suggested that there is a closer relationship between iron and copper than has hitherto been suggested (Frieden & Osaki 1969) .
REFSUM'S DISEASE
In 1945 and 1946 a condition was described by Refsum which now bears his name. Until about a year ago something under 40 cases had been described and genetic investigations have shown that it is inherited by a rare recessive gene. It is now commonly thought that the enzyme phytanic acid-a-hydroxylase is missing or is deficient.
Klenk & Kahlke (1963) demonstrated that in the blood and some tissues there was an accumulation of 3,7,11,15-tetramethyl-hexadecanoic acid or phytanic acid. This stimulated a number of other workers in an attempt to determine the nature of the defect. Since that time it has been possible to make a personal study of 22 cases: 19 patients with phytanic acid blood levels of from 6-3% to 37-0% of total fatty acids and 3 with CSF levels of 7-0%, 15-6% and 22-5%. Tissues from 6 cases have been examined, 2 without previous blood examinations and in a further case formalin fixed nerve was available. The sex distribution and age range are also shown in Table 4 . One typical case under the care of Profesr R Gilliatt showed the following features: The patient was almost 24 when she died, having shown an abnormal gait from the age of 15 years as well as being somewhat backward intellectually; when 16 years of age a diagnosis of Friedreich's ataxia and peroneal muscular atrophy was made. Later still there was difficulty in arm movenments and slight numbness. Her ataxia became worse and, when examined a few weeks before death, was of a cerebellar type; she showed tapetoretinal degeneration, hypertrophic polyneuropathy with thickened ulnar, sural and great auricular nes. There was some bulbar weakness, necestating the use of a reiatwor for one week before death. The erbrospil fluid contained 1l4g ofprotein per lOOml and the serum phytanic acid was 313 % of total fatty acids. The determinaion of phytanic acid in a nerve at autopsy or biopsy has been made in 5 cases with results seen in Table 5 . The rests in tissues obtained in 4 cases revealed a large amoumt of phytanic acid in the liver and heart but much aller amounts in the brain (see Table 6 ). The result of the analysis of the brain and organs of thepatient whoeclinical findingwere mentioned earlier are those shown in the last cohlmn. There are a few inr featus worthy of note. Levels of phytanic acid in the brain are low, but there is as much as 14-9% of phytadic acid (of total fatty acids) in the choroid and pigment layer, Table 7 ). It is of co interest that while the orgams, the periph nrves, cerbrospinal fd and even parts of the retina contain an excess of phytanic acid, the brain contains only small amounts and the so-called blood brain barrier must be relavely im b to phytanic acid.
As also shown previously (Skrbic & np, s 1969), changs are preset in liver, heart and kidney, not only as regards phytanic acid content but also in lels ofcholstxrol. Dcath ofa patient may well be associated with thes choleseol infiltrations rather than an increase in an unusul fatty acid. Nadler 1969) . In the case of Refsum's disease it seems less likely that this technique has much to offer, but in some of the lipidoses, as will be mentioned later, as well as in Duchenne muscular dystrophy, this procedure could be of the utmost importance and it is a field which has already received considerable attention, particularly in children's hospitals in this country and in Germany.
LIPIDOSES
Another group of metabolic disorders where an inborn error is present is that involving tissue deposition of some lipid. This is a vast subject and investigations of these conditions have been in progress in my laboratory since 1952, and during this period 784 brains have been studied in a variety of clinical conditions. Using a nomenclature in common use, I have listed some of these in Table 8 and for the opportunity to study this material I am indebted to clinicians and pathologists in this country and from many places abroad. Of the twelve abnormal groups there are at least seven conditions now known to be associ-ated with an enzyme defect present from or before birth. It is probable that only the last four will be of different etiology but even this is uncertain.
The initial descriptions and definitions of these conditions were the work of neurologists and physicians, who recorded in detail the signs and symptoms of each patient seen, sometimes, as in Tay-Sachs disease, with assistance from an ophthalmologist. Histologists then proceeded to the anatomical minutia of the brain (and retina) in these conditions and the German pathologists as well as Dr Greenfield were particularly prominent. In recent years the electron microscope has enabled workers like Terry and Zeman to demonstrate certain special characteristics. Meanwhile, neurochemists such as Klenk were elucidating the nature of the deposited and stored lipid, followed later by a study of the metabolic pathways of the various lipids. It was a short step to the identification of the enzymes responsible for each metabolic step and from there to theories as to the defect in disease processes. The final step, thus far, is the discovery, as suspected by some already, that the lipid changes in many of these diseases are not localized to the brain but can be detected in many organs or even in biological fluids. It must, I think, be assumed that with Details of the metabolic pathways involved in the m ism of the vwious apii can be found illustratedin various books andjournals, but in order to demontrate them e"sily prior to recording the results that have been obtained ;WO-ar mainly. presnt in tho I cortex, a uh cs are present m the white mater. It has been shown that they ar inm-ased in incy at the sme period of time that-myelin is being laid down (Cumings et at. 1958). More recently it was demonstrated that they were present in microsomes (Thompson et at. 1967) but not normally found in White matter myelin, while in later e iments they were found in syntosomes.
findings have recnly been confirmed by Halaris & Jatzkewitz (1969) in some electron histochemical studies. When the gangiosides were studied by us on thin-layer chromatography it was shown that the were a number of direrent components ( Svemierholm (1963) : GMI, GDI, GD,, and GT1, otaining one or more N-a_etnr c acid reSi . In the metabolic pahway other pngliosidelfracions,asGM2, are forned but thes are not found in the norma subject except in trace amounts, altugh in some diseas they are present in larger amounts. Metion was made just now that in some of thse there is recogized to be evidence of a widespread abnormality with a lipid deposited in an orgn such as the kidney, as well as in the brain, whike in som is es he mic abnormality present in the brain can also be detected in biologial fids and im tissuet culte of in fibroblasts or in the amniotic fltid of-the mothr. We have been engaged in lipid studies since 1952 and in these 18 years a large selection of material has been studied. Table 9 lists some of the major conditions in which cerebral lipids have been assayed, but many diseases are omitted, and only a few can be mentioned in any detail. Table 9 condenses the findings in seven disorders and includes the number ofcases personally examined, the lipid abnormality detected in each, the enzyme involved, the site where they can be detected and the degree of reduction of the enzyme in each disease. Previous communications have included discussions on various aspects, both in general clinical and biochemical terms (Cumings 1965) and in basic biochemical aspects (Booth et al. 1966 , Cumings et al. 1968 ) in a number of these disorders. Some additional comments will be made in one relatively rare condition known as Fabry's disease, for four such cases have been studied and have not yet been published.
Case History I am indebted to the late Dr P Sandifer for the history of the patient, aged 31 when he died; he, the younger by three years of two brothers, showed when examined nine years earlier, the typical clinical picture of Fabry's disease. There were severe pains of the periphery of the legs and genitalia since childhood, skin angiomata were present and albuminuria was a feature. There was papilloedema in childhood, ulcerative colitis in the teens and a later cerebral vascular accident with a resultant partial aphasia. The older of the two brothers died some four years before the younger, and I am grateful to Professor William The analysis of the kidneys of both cas, ofthe liver and the scatic nre of one compared with a normal kidney, gave the following results: the thin-layr c of the lipid extact of the kidney wastained for the ceramide component and analysis ofeach band for sph ne content ws made by a method previously desribed (umg et al. 1968 ) and comparison made with a normal kidney. It is seen Table 10 that there is a striking increase in ceramide trihexoside with a reduction in the tetraexoside component. It should also be metioned that in the brain no abnormality was detected. The The group of disorders commonly known as maurotic familial idiocy (AFI) will be commented upon as many problems arise as to classification. In. 1896 Sachs sugested the term 'amaurotic family idiocy' and dined it as a genetically con lled disorder with certain chaacteristic cinical featurs, such as the retina changes. During the next few years this label covered a variety of conditions, but in 1905 Vogt separated two forms, infantile Tay-Sachs and a juvenile form, an opinion su d by Spielmeyer (1905) . Since then clinica and pathologists have divided up the juvenile, form into a number of subgroups including a late or adult form (Kufs 1925) . Zeman (1970) has recently presented a historical survey and brought the subject up to date.
Tay-Sachs disease with a raised content of ganglioside in the oerebral cortex was for a number of years considered a ingle disea cntity with a characteristic gaiosuide abnormality (Miklner et al. 1962) . Rently it was demonstrate that in the typical case hexosaminidase A was missg and this is now aed Type 1. There appear to be two other types: in Type 2 there is an absence of well as the brain, showed a typical ganglioside picture on thin-layer chromatography with a Biopsy marked increase in GM, (see Fig 5) . In this case Biopsy Autopsy -Dr R B Ellis of the Institute of Child Health examined a small portion of brain and demon-Biopsy strated a reduction of P-D-galactosidase to 30% ofnormal.
Two brothers (K P and P P) classed as atypical Brien 1969) while in are included showing normal ganglioside levels I diminution of Nand lesser amounts of GM1 than the preceding and the condition cases, but with raised levels of GM3 and GM4 not m one brain of such seen in the other four cases. It must be stressed mined.
that the viscera all showed abnormal ganglioside nly the exceptional patterns, similar to those seen in the brain. s increased or ab-There have been 3 cases (C G, L F and A M) in obtain an increased whom there was a different ganglioside abnormebral cortex in AFI ality, GM, being reduced in amount and GDIa Lgree with this view, increased. This is illustrated in Fig 6, but unn phospholipid and fortunately the enzyme involved is not yet known; katched by an equal however, its possible site is indicated in Fig 7. the cases examined.
Finally there was one case of GM2 ganglioptions, for in 1964 sidosis of late onset (Type 3) in a boy of 5 (J N) Landing et al. described familial neurovisceral lipidosis, now often known as GM, gangliosidosis.
Zeman, from his studies, regards the Batten form as a distinct disorder which he considers to be a neuronal ceroid-lipofuscinosis (Zeman &Donahue 1963 , Zeman & Dyken 1969 .
It is, therefore, of some interest to put on record that of the 76 cases of so-called amaurotic familial idiocy, 37 have presented since 1962 when we published the first report on the presence of the abnormal Tay-Sachs ganglioside by the use of thin-layer chromatography, and of these 37 no definite abnormal ganglioside patterns of any type were found in 25. During the same period 11 cases of Tay-Sachs disease have been studied.
Nine of the 37 cases studied since 1962 showing abnormal ganglioside pattemns together with one other case are shown in Table 11 . These cases are extremely interesting; the first was a patient who died in 1964 aged 32, having been described clinically in some detail by Glasgow in 1957. Unfortunately, no cerebral tissue was examined during life, and the initial studies on this patient were made five years before our use of thin-layer (1963) BCumings et al. (1971) who was still alive three yea later. Estimated amounts of oside in eah fraction in some of thee cases are seen in Table 12 , confirming the macroscopic inspection of the thin-layer chromatogram.
I must comment briefly concerning the problem of the cl tion of some of these conditions. In general, the term idosis can be applied to six disorders affecting the brain, for in all of them sphisine is a component part of the lipid stored or present in excess i the tissues.
Four of them, Gaucher, Niemann-Pick, Kabbe and metachromatic leukodystrophy, present few problems. In the other two conditions, Tay-Sachs and amaurotic familial idiocy, it is possible on a biochmical and histological basis to separate these into a number of subgroups Ther are now known to be thre types of Tay-Sachs disorder depending upon the enzyme affectd, en though all show a raised GM ganglioside level as well as the characteristic EM appearance. Amongst the group of conditions called amaurotic familial idiocy there is firstly the variety described by Zeman as ceroid-lipofuscinosis with no abnormnality in quantity or type of ganglioside but with a characteristic histological picture. This corresponds to the so-called Batten type. Secondly, there is the Landing et al. type of neurovisceral lipidosis with an increase of GM, and with a known enzymic abnormality. Finally, ther may be a group in which there is an increase of GQDI of which we have seen three cases, and in which the actual enzyme involved is not yet identified.
Ther is thus a large field among the remaining types of amaurotic familial idiocy which must be delineated more accurately before we can arrive at an exact classification ofall the clinical varieties of this-disorder, and it is hoped that some stimulus will have been given for furth re rch in this and related metabolic diseass.
